EUVIMEDEUVIMED entdecken
Crossref

Allosteric Inhibition of the β 2 ‐Adrenergic Receptor: Design and Synthesis of Cmpd‐15 Analogs

Kexin Ye, Qing Li, Zhijie Luo, Qianchen Lu, Xue Rui, Yan Li, Jie Jin, Chenchen Jing, Meiling Hong, Mingcheng Qian, Shuai Zhao, Yanan Hou und 1 weitere

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202401420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Kexin Ye und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Changzhou University, Jiangsu, 213164, China. Hauptthemen laut MEDLINE: Drug Design, Receptors, Adrenergic, beta-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We designed and synthesized 27 new amide and dipeptide derivatives containing a substituted phenylalanine as negative allosteric modulators (NAMs) for the beta‐2 adrenergic receptor (β 2 AR). These analogs aimed to improve the activity of our lead compound, Cmpd‐15, by introducing variations in three key regions: the meta ‐bromobenzyl methylbenzamide (S1), para ‐formamidophenylalanine (S2), and 1‐cyclohexyl‐1‐phenylacetyl (S3) groups. The synthesis involved the Pd‐catalyzed β‐C(sp 3 )‐H arylation of N‐acetylglycine with 1‐iodo‐4‐substituent‐benzenes as the key step. GloSensor cAMP accumulation assay revealed that six analogs ( A 1 , C 5 , C 6 , C 13 , C 15 and C 17 ) surpass Cmpd‐15 in β 2 AR allosteric function. This highlights the crucial role of the S1 region ( meta ‐bromobenzyl methylbenzamide) in β 2 AR allostery while suggesting potential replaceability of the S2 region ( para ‐formamidophenylalanine). These findings serve as a valuable springboard for further optimizing Cmpd‐15, potentially leading to smaller, more active, and more stable β 2 AR‐targeting NAMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignReceptors, Adrenergic, beta-2Allosteric RegulationHumansStructure-Activity RelationshipMolecular StructureBenzamidesAdrenergic beta-2 Receptor AntagonistsDose-Response Relationship, Drug

Stichwörter der Autor:innen

Negative allosteric modulatorPalladium-catalyzed C−H arylationStructure-activity relationships.β2-Adrenergic receptor

Substanzen

Receptors, Adrenergic, beta-2BenzamidesAdrenergic beta-2 Receptor Antagonists

Autor:innen und Institutionen

  • School of Pharmacy, Changzhou University, Jiangsu, 213164, China.

ORCID-Profile: Xin Chen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ye, K., Li, Q., Luo, Z., Lu, Q., Rui, X., Li, Y., Jin, J., Jing, C., Hong, M., Qian, M., Zhao, S., Hou, Y., & Chen, X. (2025). Allosteric Inhibition of the β 2 ‐Adrenergic Receptor: Design and Synthesis of Cmpd‐15 Analogs. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401420

Vancouver

Ye K, Li Q, Luo Z, Lu Q, Rui X, Li Y, et al. Allosteric Inhibition of the β 2 ‐Adrenergic Receptor: Design and Synthesis of Cmpd‐15 Analogs. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202401420

BibTeX
@article{Ye2025,
  author = {Ye, Kexin and Li, Qing and Luo, Zhijie and Lu, Qianchen and Rui, Xue and Li, Yan and Jin, Jie and Jing, Chenchen and Hong, Meiling and Qian, Mingcheng and Zhao, Shuai and Hou, Yanan and Chen, Xin},
  title = {Allosteric Inhibition of the β 2 ‐Adrenergic Receptor: Design and Synthesis of Cmpd‐15 Analogs},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202401420}
}
Kostenlos starten →